Debt-to-equity of Regenerative Medical Technology Group Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regenerative Medical Technology Group Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Regenerative Medical Technology Group Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -115%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Regenerative Medical Technology Group Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -115% 30 Sep 2025
Q2 2024 -113% +48% +30% 30 Jun 2024
Q1 2024 -120% +46% +27% 31 Mar 2024
Q4 2023 -130% +47% +26% 31 Dec 2023
Q3 2023 -143% +48% +25% 30 Sep 2023
Q2 2023 -161% +74% +31% 30 Jun 2023
Q1 2023 -166% +118% +42% 31 Mar 2023
Q4 2022 -177% +83% +32% 31 Dec 2022
Q3 2022 -191% +26% +12% 30 Sep 2022
Q2 2022 -235% -114% -95% 30 Jun 2022
Q1 2022 -284% -181% -177% 31 Mar 2022
Q4 2021 -260% -159% -159% 31 Dec 2021
Q3 2021 -217% -117% -117% 30 Sep 2021
Q2 2021 -120% -21% -21% 30 Jun 2021
Q1 2021 -103% -3% -3% 31 Mar 2021
Q4 2020 -100% -0.47% -0.47% 31 Dec 2020
Q3 2020 -100% +0.37% +0.37% 30 Sep 2020
Q2 2020 -100% 30 Jun 2020
Q1 2020 -100% 31 Mar 2020
Q4 2019 -100% 31 Dec 2019
Q3 2019 -100% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.